There is substantial evidence on efficient pharmacotherapy including, e.g. beta-blockers, angiotensin-converting enzyme inhibitors, antiotensin-II receptor blockers, statins, antiplatelet and anticoagulative agents in addition to non-pharmacotherapeutic intervention including, e.g. smoking cessation, rehabilitation and physical exercise in preventing cardiovascular outcomes in CAD and post-MI patients [27]. This evidence concerns the gene ACE and myocardial infarction.